Vsee Health Inc stock drops significantly amid market gains
Vsee Health Inc's stock price fell sharply by 22.71% as it crossed below its 5-day SMA, indicating a significant downward trend in its performance.
The decline in Vsee Health's stock comes despite the broader market's positive performance, with the Nasdaq-100 up 0.85% and the S&P 500 up 0.54%. This suggests a sector rotation, where Vsee Health's stock is moving against the overall market trend.
Investors may need to reassess their positions in Vsee Health as the stock's recent performance diverges from the general market strength, indicating potential underlying issues within the company.
Trade with 70% Backtested Accuracy
Analyst Views on VSEE
About VSEE
About the author
VSee Health Reports 40.3% Revenue Growth for FY
- Fiscal Year Revenue Growth: VSee Health reported a fiscal year revenue of $14.62 million, reflecting a robust 40.3% year-over-year growth, which underscores the company's strong momentum in the telehealth sector and solidifies its market position.
- Significant Cash Flow Improvement: As of December 31, 2025, the company's cash and cash equivalents surged to $5,266,286 from $326,115 in 2024, enhancing financial stability and enabling future investment opportunities.
- Gross Margin Increase: Gross profit rose from $7,177,580 to $7,355,965, with a 2% increase in gross margin, indicating ongoing improvements in cost control and operational efficiency, which contribute to overall profitability enhancement.
- Sharp Decline in Operating Expenses: Operating expenses plummeted by 76%, optimizing the company's cost structure and laying the groundwork for future profit growth, demonstrating effective resource allocation by management.
VSee Health Partners with DocBox for AI-Driven ICU Platform
- Strategic Partnership: VSee Health has entered a strategic partnership with DocBox to develop an augmented intelligence platform for virtual ICUs, enhancing remote critical care capabilities for hospitals worldwide.
- Data Integration: DocBox's real-time, vendor-agnostic bedside data infrastructure will be integrated into VSee's telehealth platform, embedding augmented intelligence directly into live ICU clinical workflows to improve clinical decision-making efficiency.
- Clinical Intelligence: The joint platform will convert continuous bedside device data into actionable clinical intelligence, supporting scalable remote critical care delivery and optimizing hospital operational efficiency.
- Data Ownership: The platform allows hospitals to retain ownership of their clinical data while enabling automated billing capture and deployment of AI tools, further solidifying VSee's market position in AI-enabled virtual healthcare.
Vision Marine Technologies Stock Rises Over 10%; Check Out 20 Stocks Making Moves in Premarket Trading
Vision Marine Technologies Performance: Vision Marine Technologies Inc. shares rose 10.5% to $1.36 in pre-market trading after announcing strong financial results for the fiscal year ending August 31, 2025, and highlighting strategic expansion following the acquisition of Nautical Ventures, which generated $12.8 million in revenue.
Other Gainers in Pre-Market Trading: Several stocks saw significant gains in pre-market trading, including WEBUY Global Ltd. (+62.1%), Direct Digital Holdings, Inc. (+60.6%), and INVO Fertility, Inc. (+24.7%), with various companies announcing acquisitions or strategic plans.
Notable Losers in Pre-Market Trading: SMX (Security Matters) PLC experienced a sharp decline of 24.6% after a previous surge, while Springview Holdings Ltd. fell 20.7% following a reverse share split announcement.
Market Overview: The pre-market trading session showed a mix of gains and losses across various stocks, with some companies like New Fortress Energy Inc. and Canadian Solar Inc. also reporting notable increases.
Teradyne Shares Surge Over 20%; Check Out 20 Stocks Making Moves in Premarket Trading
Teradyne's Strong Performance: Teradyne Inc. shares surged 20.7% in pre-market trading after reporting third-quarter earnings of 85 cents per share, exceeding analyst expectations of 79 cents, along with sales of $769.210 million, surpassing the $743.776 million estimate.
Notable Gainers: Several stocks saw significant pre-market gains, including Profusa Inc. (+72.8%), Founder Group Ltd (+59.4%), and Vsee Health Inc. (+44.3%), driven by positive developments such as manufacturing capacity increases and regulatory approvals.
Major Losers: Stride Inc. experienced a sharp decline of 36.4% after providing disappointing sales guidance, while Varonis Systems Inc. and Akebia Therapeutics Inc. also fell significantly due to lower-than-expected revenue and trial design issues, respectively.
Market Overview: The pre-market trading session showed a mix of gains and losses across various stocks, with notable movements in both directions, reflecting investor reactions to earnings reports and company announcements.
What Caused VSee Health's Stock to Surge More Than 45% Overnight?
Stock Surge: VSee Health Inc. saw a significant increase in its stock price, rising 45.28% to $1.54 in after-hours trading, following a 71.66% increase during regular trading hours.
Federal Authorization: The company received FedRAMP High authorization from the Department of Health and Human Services, enabling federal agencies to utilize its telehealth platform for secure patient care.
Financial Performance: VSee reported a revenue of $3.4 million for the second quarter, marking a 98% increase year-over-year, with a gross profit margin improvement to 47%.
Market Trends: Despite a year-to-date decline of 22.06%, VSee's stock has surged 68.25% over the past month, although it has a negative price trend across all time frames according to Benzinga Edge Stock Rankings.
Crude Oil Drops More Than 2%; PayPal Stock Rises Sharply
U.S. Stock Market Performance: U.S. stocks saw gains, with the Dow up 0.39%, Nasdaq rising 0.42%, and S&P 500 increasing by 0.07%. Information technology shares led the rise, while real estate stocks fell by 1.6%.
PayPal's Strong Performance: PayPal's stock surged 12% after announcing a collaboration with OpenAI, reporting a 7% year-over-year revenue growth to $8.42 billion, and exceeding earnings expectations.
Notable Stock Movements: Vsee Health's shares skyrocketed 221% after receiving operational authority, while Arcutis Biotherapeutics and Wayfair also saw significant gains. Conversely, Co-Diagnostics and Alexandria Real Estate Equities experienced substantial declines.
Global Market Trends: European shares were mixed, with the STOXX 600 down 0.32%, while Asian markets closed lower. In economic news, U.S. house prices rose 0.4% month-over-month in August, and private businesses added an average of 14,250 jobs weekly.
VSee Health Reports 40.3% Revenue Growth for FY
- Fiscal Year Revenue Growth: VSee Health reported a fiscal year revenue of $14.62 million, reflecting a robust 40.3% year-over-year growth, which underscores the company's strong momentum in the telehealth sector and solidifies its market position.
- Significant Cash Flow Improvement: As of December 31, 2025, the company's cash and cash equivalents surged to $5,266,286 from $326,115 in 2024, enhancing financial stability and enabling future investment opportunities.
- Gross Margin Increase: Gross profit rose from $7,177,580 to $7,355,965, with a 2% increase in gross margin, indicating ongoing improvements in cost control and operational efficiency, which contribute to overall profitability enhancement.
- Sharp Decline in Operating Expenses: Operating expenses plummeted by 76%, optimizing the company's cost structure and laying the groundwork for future profit growth, demonstrating effective resource allocation by management.
VSee Health Partners with DocBox for AI-Driven ICU Platform
- Strategic Partnership: VSee Health has entered a strategic partnership with DocBox to develop an augmented intelligence platform for virtual ICUs, enhancing remote critical care capabilities for hospitals worldwide.
- Data Integration: DocBox's real-time, vendor-agnostic bedside data infrastructure will be integrated into VSee's telehealth platform, embedding augmented intelligence directly into live ICU clinical workflows to improve clinical decision-making efficiency.
- Clinical Intelligence: The joint platform will convert continuous bedside device data into actionable clinical intelligence, supporting scalable remote critical care delivery and optimizing hospital operational efficiency.
- Data Ownership: The platform allows hospitals to retain ownership of their clinical data while enabling automated billing capture and deployment of AI tools, further solidifying VSee's market position in AI-enabled virtual healthcare.
Vision Marine Technologies Stock Rises Over 10%; Check Out 20 Stocks Making Moves in Premarket Trading
Vision Marine Technologies Performance: Vision Marine Technologies Inc. shares rose 10.5% to $1.36 in pre-market trading after announcing strong financial results for the fiscal year ending August 31, 2025, and highlighting strategic expansion following the acquisition of Nautical Ventures, which generated $12.8 million in revenue.
Other Gainers in Pre-Market Trading: Several stocks saw significant gains in pre-market trading, including WEBUY Global Ltd. (+62.1%), Direct Digital Holdings, Inc. (+60.6%), and INVO Fertility, Inc. (+24.7%), with various companies announcing acquisitions or strategic plans.
Notable Losers in Pre-Market Trading: SMX (Security Matters) PLC experienced a sharp decline of 24.6% after a previous surge, while Springview Holdings Ltd. fell 20.7% following a reverse share split announcement.
Market Overview: The pre-market trading session showed a mix of gains and losses across various stocks, with some companies like New Fortress Energy Inc. and Canadian Solar Inc. also reporting notable increases.
Teradyne Shares Surge Over 20%; Check Out 20 Stocks Making Moves in Premarket Trading
Teradyne's Strong Performance: Teradyne Inc. shares surged 20.7% in pre-market trading after reporting third-quarter earnings of 85 cents per share, exceeding analyst expectations of 79 cents, along with sales of $769.210 million, surpassing the $743.776 million estimate.
Notable Gainers: Several stocks saw significant pre-market gains, including Profusa Inc. (+72.8%), Founder Group Ltd (+59.4%), and Vsee Health Inc. (+44.3%), driven by positive developments such as manufacturing capacity increases and regulatory approvals.
Major Losers: Stride Inc. experienced a sharp decline of 36.4% after providing disappointing sales guidance, while Varonis Systems Inc. and Akebia Therapeutics Inc. also fell significantly due to lower-than-expected revenue and trial design issues, respectively.
Market Overview: The pre-market trading session showed a mix of gains and losses across various stocks, with notable movements in both directions, reflecting investor reactions to earnings reports and company announcements.
What Caused VSee Health's Stock to Surge More Than 45% Overnight?
Stock Surge: VSee Health Inc. saw a significant increase in its stock price, rising 45.28% to $1.54 in after-hours trading, following a 71.66% increase during regular trading hours.
Federal Authorization: The company received FedRAMP High authorization from the Department of Health and Human Services, enabling federal agencies to utilize its telehealth platform for secure patient care.
Financial Performance: VSee reported a revenue of $3.4 million for the second quarter, marking a 98% increase year-over-year, with a gross profit margin improvement to 47%.
Market Trends: Despite a year-to-date decline of 22.06%, VSee's stock has surged 68.25% over the past month, although it has a negative price trend across all time frames according to Benzinga Edge Stock Rankings.
Crude Oil Drops More Than 2%; PayPal Stock Rises Sharply
U.S. Stock Market Performance: U.S. stocks saw gains, with the Dow up 0.39%, Nasdaq rising 0.42%, and S&P 500 increasing by 0.07%. Information technology shares led the rise, while real estate stocks fell by 1.6%.
PayPal's Strong Performance: PayPal's stock surged 12% after announcing a collaboration with OpenAI, reporting a 7% year-over-year revenue growth to $8.42 billion, and exceeding earnings expectations.
Notable Stock Movements: Vsee Health's shares skyrocketed 221% after receiving operational authority, while Arcutis Biotherapeutics and Wayfair also saw significant gains. Conversely, Co-Diagnostics and Alexandria Real Estate Equities experienced substantial declines.
Global Market Trends: European shares were mixed, with the STOXX 600 down 0.32%, while Asian markets closed lower. In economic news, U.S. house prices rose 0.4% month-over-month in August, and private businesses added an average of 14,250 jobs weekly.
